Brief: Pacira Biosciences, Announces Pricing Of $250.0 Million Aggregate Principal Amount Of 2.125% Convertible Senior Notes Due 2029
10/05/2024 12:07
May 10 (Reuters) - Pacira Biosciences Inc PCRX.O :
* PACIRA BIOSCIENCES, INC. ANNOUNCES PRICING OF $250.0
MILLION
AGGREGATE PRINCIPAL AMOUNT OF 2.125% CONVERTIBLE SENIOR NOTES
DUE 2029
* PACIRA CONVERTIBLE SENIOR NOTES MATURITY SET FOR MAY 15,
2029
Source text for Eikon: ID:nGNX5GH1D0
Further company coverage: PCRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pacira BioSciences
See all newsUS STOCKS ON THE MOVE-Palantir, Haemonetics
U.S. STOCKS ON THE MOVE-Palantir, Haemonetics, Starbucks
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal
Brief: Viatris - Pacira To Pay Viatris $62 Million Termination Fee Under Specified Circumstances
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal